# Insights from the CBD Autism Anxiety Clinical Trial Study > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cbd-autism-anxiety-trial-results/ > **Published:** 2026-04-26T00:26:59-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:57:17-04:00 > **Clinical Summary:** Explore the CBD autism anxiety trial results showing improvements in social interaction and reduced anxiety in autistic children from a controlled clinical study. --- #### Clinical Takeaway This randomized controlled trial found that CBD oil at 10 mg/kg daily showed measurable improvements in social interaction, anxiety symptoms, and parental stress levels in autistic children aged 5-12 years compared to placebo. The double-blind crossover design provides moderate [clinical evidence](https://cedclinic.com/academic-partnerships-cannabis-research/) that CBD may have therapeutic utility for specific behavioral and emotional symptoms associated with autism spectrum disorder. Further larger studies are needed to establish optimal dosing, long-term safety, and which autistic children are most likely to benefit from this intervention. ### #27 Effects of Cannabidiol on Social Relating, Anxiety, and Parental Stress in Autistic Children: A Randomized Controlled Crossover Trial. **Citation:** Parrella Nina-Francesca et al. *Effects of Cannabidiol on Social Relating, Anxiety, and Parental Stress in Autistic Children: A Randomized Controlled Crossover Trial.* Autism research: official journal of the International Society for Autism Research. 2026. PMID: 41452412. **Study type:** Journal Article, Randomized Controlled Trial  |  **Topic area:** Autism  |  **CED Score:** 10 Design: 5 Journal: 0 N: 0 Recency: 3 Pop: 3 Human: 1 Risk: -2 **Quality Gate Alerts:** - Preclinical only **Abstract:** Cannabidiol (CBD), a non-intoxicating compound derived from the cannabis plant, has garnered increasing attention as a potential pharmacological therapeutic for autism. We conducted a randomized, double-blind, placebo-controlled, crossover trial to understand whether oral CBD oil containing terpenes can improve outcomes in autistic children. Twenty-nine children (18 male), aged 5 to 12 years (M = 9.62 years, SD = 2.05), diagnosed with autism spectrum disorder, completed the study. Participants received weight-based dosing of CBD oil (10 mg/kg/day) or matched placebo oil over two 12-week intervention periods (crossover), separated by an 8-week washout period. Outcome measures included the Social Responsiveness Scale-2 (SRS-2; primary outcome), PROMIS Social Relating, Anxiety, and Sleep, Developmental Behavior Checklist-2 (DBC-2), Vineland-3, and Autism Parenting Stress Index (APSI; secondary outcomes). There was no significant effect observed for the primary outcome measure (SRS-2) for CBD oil relative to placebo oil after 12 weeks (β = -11.15, SE = 7.19, p = 0.125). Significant improvements were observed in secondary measures of social functioning, including DBC-2 Social Relating (β = -2.35, SE = 0.92, p(adj) = 0.024), as well as reduced anxiety on the DBC-2 subscale (β = -3.20, SE = 0.94, p(adj) = 0.002), and lower parental stress (APSI; β = -4.63, SE = 2.26, p(adj) = 0.044). No differences were detected on Vineland-3 adaptive functioning (ABC: β = 2.06, SE = 2.67, p(adj) = 1.000), and domain scores were not significant. Safety and tolerability data indicated that two children experienced gastrointestinal discomfort while taking CBD. Findings from this pilot trial suggest that while CBD combined with terpenes did not improve the primary outcome of social responsiveness, it may hold potential in addressing certain autism-related difficulties, particularly anxiety and social relating. Further research with larger sample sizes is needed to fully evaluate the efficacy  |  [View on PubMed ↗](https://pubmed.ncbi.nlm.nih.gov/41452412/)[DOI ↗](https://doi.org/10.1002/aur.70159) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabidiol Effects on Autism Anxiety and Parental Stress](https://cedclinic.com/effects-cannabidiol-autism-anxiety-parental-stress/) Detailed exploration of cannabidiol's impact on autism-related anxiety and parental stress levels in children. [Read More](https://cedclinic.com/effects-cannabidiol-autism-anxiety-parental-stress/) [Cannabinoid Clinical Trials: CBD & Autism in Children](https://cedclinic.com/cannabinoid-clinical-benefits-autism-cbd-trial/) Comprehensive review of [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) investigating CBD use in children with autism spectrum disorder. [Explore Trials](https://cedclinic.com/cannabinoid-clinical-benefits-autism-cbd-trial/) [CBD Autism Trial: Endocannabinoid System Clinical Research](https://cedclinic.com/cannabidiol-autism-anxiety-clinical-trial-study-2/) Insights into the role of the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) in autism and results from CBD [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) trials. [Learn More](https://cedclinic.com/cannabidiol-autism-anxiety-clinical-trial-study-2/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Insights%20from%20the%20CBD%20Autism%20Anxiety%20Clinical%20Trial%20Study&url=https%3A%2F%2Fcedclinic.com%2Fcbd-autism-anxiety-trial-results%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcbd-autism-anxiety-trial-results%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Insights%20from%20the%20CBD%20Autism%20Anxiety%20Clinical%20Trial%20Study%20https%3A%2F%2Fcedclinic.com%2Fcbd-autism-anxiety-trial-results%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).